Søgeord (corona) valgt.
19 emner vises.
1
Communicable disease threats report, 31 March - 6 April 2024, week 14
ECDC
ECDC COVID-19 updates, 5.04.2024
Tilføjet 5.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 March - 6 April 2024 and includes updates on SARS-CoV-2, cholera, avian influenza A(H5N1), swine influenza A(H1N2) and Middle East respiratory syndrome coronavirus (MERS-CoV).
Læs mere
2
Communicable disease threats report, 31 March - 6 April 2024, week 14
ECDC
ECDC Communicable Disease Threats Report, 5.04.2024
Tilføjet 5.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 March - 6 April 2024 and includes updates on SARS-CoV-2, cholera, avian influenza A(H5N1), swine influenza A(H1N2) and Middle East respiratory syndrome coronavirus (MERS-CoV).
Læs mere
3
Protocol for a COVID-19 vaccine effectiveness multi-country cohort study in the paediatric population aged 5–17-years using electronic health records in EU/EEA countries
ECDC
ECDC COVID-19 updates, 15.03.2024
Tilføjet 15.03.2024
This protocol describes the common methodology to be applied to established health data registries across seven participating EU/EEA Member States to estimate vaccine effectiveness for Coronavirus disease 2019 (COVID-19) in children and adolescents aged 5-17 years old.
Læs mere
4
Communicable disease threats report, 3-9 March 2024, week 10
ECDC
ECDC COVID-19 updates, 8.03.2024
Tilføjet 8.03.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 3-9 March 2024 and includes updates on SARS-CoV-2 variant classification, sexually transmitted infections, Psittacosis cases, product safety recall of InterPharma Sodium Chloride 0.9% 30ml linked to Ralstonia pickettii contamination, cholera and Middle East respiratory syndrome coronavirus (MERS-CoV).
Læs mere
5
Communicable disease threats report, 3-9 March 2024, week 10
ECDC
ECDC Communicable Disease Threats Report, 8.03.2024
Tilføjet 8.03.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 3-9 March 2024 and includes updates on SARS-CoV-2 variant classification, sexually transmitted infections, Psittacosis cases, product safety recall of InterPharma Sodium Chloride 0.9% 30ml linked to Ralstonia pickettii contamination, cholera and Middle East respiratory syndrome coronavirus (MERS-CoV).
Læs mere
6
Projecting COVID-19 intensive care admissions for policy advice, the Netherlands, February 2020 to January 2021
Don Klinkenberg, Jantien Backer, Nicolette de Keizer and Jacco Wallinga
Eurosurveillance latest updates, 8.03.2024
Tilføjet 8.03.2024
BackgroundModel projections of coronavirus disease 2019 (COVID-19) incidence help policymakers about decisions to implement or lift control measures. During the pandemic, policymakers in the Netherlands were informed on a weekly basis with short-term projections of COVID-19 intensive care unit (ICU) admissions. AimWe aimed at developing a model on ICU admissions and updating a procedure for informing policymakers. MethodThe projections were produced using an age-structured transmission model. A consistent, incremental update procedure integrating all new surveillance and hospital data was conducted weekly. First, up-to-date estimates for most parameter values were obtained through re-analysis of all data sources. Then, estimates were made for changes in the age-specific contact rates in response to policy changes. Finally, a piecewise constant transmission rate was estimated by fitting the model to reported daily ICU admissions, with a changepoint analysis guided by Akaike\'s Information Criterion. ResultsThe model and update procedure allowed us to make weekly projections. Most 3-week prediction intervals were accurate in covering the later observed numbers of ICU admissions. When projections were too high in March and August 2020 or too low in November 2020, the estimated effectiveness of the policy changes was adequately adapted in the changepoint analysis based on the natural accumulation of incoming data. ConclusionThe model incorporates basic epidemiological principles and most model parameters were estimated per data source. Therefore, it had potential to be adapted to a more complex epidemiological situation with the rise of new variants and the start of vaccination.
Læs mere
7
Communicable disease threats report, 11-17 February 2024, week 7
ECDC
ECDC Communicable Disease Threats Report, 16.02.2024
Tilføjet 16.02.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 11-17 February 2024, and includes updates on SARS-CoV-2 variant classification, diphtheria, chikungunya, dengue, influenza A(H5N1), a human case of co-infection with seasonal influenza A(H3N2) and avian influenza A(H10N5), Middle East respiratory syndrome coronavirus (MERS-CoV), and an overview of respiratory virus epidemiology in the EU/EEA.
Læs mere
8
Communicable disease threats report, 11-17 February 2024, week 7
ECDC
ECDC COVID-19 updates, 16.02.2024
Tilføjet 16.02.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 11-17 February 2024, and includes updates on SARS-CoV-2 variant classification, diphtheria, chikungunya, dengue, influenza A(H5N1), a human case of co-infection with seasonal influenza A(H3N2) and avian influenza A(H10N5), Middle East respiratory syndrome coronavirus (MERS-CoV), and an overview of respiratory virus epidemiology in the EU/EEA.
Læs mere
9
Communicable disease threats report, 7-13 January 2024, week 2
ECDC
ECDC Communicable Disease Threats Report, 13.01.2024
Tilføjet 13.01.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 January 2024 and includes updates on SARS-CoV-2, measles, diphtheria, Middle East respiratory syndrome coronavirus (MERS-CoV) and poliomyelitis.
Læs mere
10
Communicable disease threats report, 7-13 January 2024, week 2
ECDC
ECDC COVID-19 updates, 12.01.2024
Tilføjet 12.01.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7-13 January 2024 and includes updates on SARS-CoV-2, measles, diphtheria, Middle East respiratory syndrome coronavirus (MERS-CoV) and poliomyelitis.
Læs mere
11
Efterårets covid-19-vacciner reducerer risikoen for indlæggelse med 75 procent
Statens Serum Institut, 16.11.2023
Tilføjet 16.11.2023
De variantopdaterede covid-19-vacciner, som er rettet mod nyere varianter af coronavirus, og som er blevet givet siden oktober i år, giver god beskyttelse mod alvorlig sygdom.
Læs mere
12
The European Respiratory Virus Surveillance Summary (ERVISS)
ECDC
ECDC COVID-19 updates, 25.10.2023
Tilføjet 25.10.2023
This interactive dashboard provides a weekly integrated epidemiological summary for influenza, respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Læs mere
13
ECDC and WHO launch new surveillance tool for respiratory viruses to improve early detection
ECDC
ECDC COVID-19 updates, 25.10.2023
Tilføjet 25.10.2023
ECDC and World Health Organization (WHO) Regional Office for Europe have jointly developed the European Respiratory Virus Surveillance Summary (ERVISS), an interactive surveillance data dashboard for influenza, respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that also features a weekly epidemiological summary.
Læs mere
14
COVID Coronary Plaque Infection Confirms CV Risk
Medscape Infectious Diseases, 24.10.2023
Tilføjet 24.10.2023
Evidence showing the SARS-CoV-2 virus directly infects coronary atherosclerotic plaques, causing a persistent inflammatory response, may lead to new approaches for managing patients after infection. Medscape Medical News
Læs mere
15
Implementation of a broad public health approach to COVID-19 in Sweden, January 2020 to May 2022
Anders Tegnell, Anna Bessö, Britta Björkholm, Sara Byfors, Johan Carlson and Karin Tegmark Wisell
Eurosurveillance latest updates, 13.10.2023
Tilføjet 13.10.2023
In 2020, the world had to adapt to a pandemic caused by a then novel coronavirus. In addition to its direct impact on morbidity and mortality, the COVID-19 pandemic brought unprecedented control measures and challenges to both individuals and society. Sweden has been seen by many as an outlier in the management of the pandemic. It is therefore of special interest to document the actual management of the pandemic in Sweden during its first 2 years and how public health was affected. In the authors opinion, within the Swedish context, it has been possible to achieve a similar level of effect on mortality and morbidity through recommendations as was achieved through stringent legal measures in comparable countries. This is supported by comparisons of excess mortality that have been published. Furthermore, we see in the available data that the consequences on mental health and living habits were very limited for the majority of the population. Trust in public institutions is high in Sweden, which has been important and is part of the context that made it possible to manage a pandemic with relatively ‘soft’ measures. We acknowledge challenges in protecting certain vulnerable groups, particularly during the first and second wave.
Læs mere
16
COVID-19 Virus Infects Coronary Vasculature
Medscape Infectious Diseases, 29.09.2023
Tilføjet 29.09.2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is found in coronary arteries of patients who died of COVID-19. Medscape Medical News
Læs mere
17
Den usædvanlige virusvariant BA.2.86 er nu videnskabeligt beskrevet af SSI
Statens Serum Institut, 11.09.2023
Tilføjet 11.09.2023
Statens Serum Institut i samarbejde med regionale afdelinger for klinisk mikrobiologi har offentliggjort en artikel i det videnskabelige tidsskrift Eurosurveillance, der beskriver de første ti tilfælde af coronavirusvarianten BA.2.86, der er påvist i Danmark.
Læs mere
18
First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
Morten Rasmussen, Frederik Trier Møller, Vithiagaran Gunalan, Sharmin Baig, Marc Bennedbæk, Lasse Engbo Christiansen, Arieh Sierra Cohen, Kirsten Ellegaard, Anders Fomsgaard, Kristina Træholt Franck, Nicolai Balle Larsen, Tine Graakjær Larsen, Ria Lassaunière, Charlotta Polacek, Amanda Gammelby Qvesel, Raphael Niklaus Sieber, Lasse Dam Rasmussen, Marc Stegger, Katja Spiess, Man-Hung Eric Tang, Lasse Skafte Vestergaard, Thomas Emil Andersen, Silje Vermedal Hoegh, Rune Micha Pedersen, Marianne Nielsine Skov, Kat Steinke, Thomas Vognbjerg Sydenham, Morten Hoppe, Lene Nielsen, Tyra Grove Krause, Henrik Ullum and Pikka Jokelainen
Eurosurveillance latest updates, 8.09.2023
Tilføjet 8.09.2023
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.
Læs mere
19
Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - Third update
ECDC
ECDC COVID-19 updates, 23.08.2023
Tilføjet 23.08.2023
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
Læs mere